These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 34682915)

  • 1. Glycation and Glycosylation in Cardiovascular Remodeling: Focus on Advanced Glycation End Products and O-Linked Glycosylations as Glucose-Related Pathogenetic Factors and Disease Markers.
    Dozio E; Massaccesi L; Corsi Romanelli MM
    J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area.
    Toivonen MH; Pöllänen E; Ahtiainen M; Suominen H; Taaffe DR; Cheng S; Takala T; Kujala UM; Tammi MI; Sipilä S; Kovanen V
    Exp Gerontol; 2013 Dec; 48(12):1501-4. PubMed ID: 24365779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.
    Neviere R; Yu Y; Wang L; Tessier F; Boulanger E
    Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic role of dietary advanced glycation end products in cardiometabolic disorders, and therapeutic intervention.
    Yamagishi S; Matsui T
    Nutrition; 2016 Feb; 32(2):157-65. PubMed ID: 26602289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycation With Fructose: The Bitter Side of Nature's Own Sweetener.
    Amani S; Fatima S
    Curr Diabetes Rev; 2020; 16(9):962-970. PubMed ID: 32013850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of O-linked protein glycosylation in beta-cell dysfunction.
    Konrad RJ; Kudlow JE
    Int J Mol Med; 2002 Nov; 10(5):535-9. PubMed ID: 12373287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia driven glycation: Mechanisms and therapeutic opportunities.
    Khan MI; Rath S; Adhami VM; Mukhtar H
    Semin Cancer Biol; 2018 Apr; 49():75-82. PubMed ID: 28546110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications.
    Mengstie MA; Chekol Abebe E; Behaile Teklemariam A; Tilahun Mulu A; Agidew MM; Teshome Azezew M; Zewde EA; Agegnehu Teshome A
    Front Mol Biosci; 2022; 9():1002710. PubMed ID: 36188225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.
    Isono T
    PLoS One; 2011 Apr; 6(4):e18959. PubMed ID: 21526146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sugar-coated bullets: Unveiling the enigmatic mystery 'sweet arsenal' in osteoarthritis.
    Liu HZ; Song XQ; Zhang H
    Heliyon; 2024 Mar; 10(6):e27624. PubMed ID: 38496870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2f1 deletion attenuates infarct-induced ventricular remodeling without affecting O-GlcNAcylation.
    Dassanayaka S; Brittian KR; Jurkovic A; Higgins LA; Audam TN; Long BW; Harrison LT; Militello G; Riggs DW; Chitre MG; Uchida S; Muthusamy S; Gumpert AM; Jones SP
    Basic Res Cardiol; 2019 May; 114(4):28. PubMed ID: 31152247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of the advanced glycation end products (AGEs) and their receptor (RAGE) system is a possible mechanism for sustained beneficial effects of multifactorial intervention on mortality in type 2 diabetes.
    Yamagishi S; Matsui T; Nakamura K
    Med Hypotheses; 2008 Nov; 71(5):749-51. PubMed ID: 18710793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
    Melin EO; Dereke J; Hillman M
    Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the correlation of the expression level of hypoxia-inducible factor-1α with the glycosylation of oral squamous cell carcinoma.
    Xu X; Liu H; Wu R; Zuo W; Wang T; Chen D
    Am J Transl Res; 2021; 13(6):6686-6693. PubMed ID: 34306413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women.
    Pertynska-Marczewska M; Merhi Z
    Reprod Sci; 2015 Jul; 22(7):774-82. PubMed ID: 25228634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.
    Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-enzymatic glycation of proteins: from diabetes to cancer].
    Ansari NA; Rasheed Z
    Biomed Khim; 2010; 56(2):168-78. PubMed ID: 21341505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation.
    Sourris KC; Watson A; Jandeleit-Dahm K
    Handb Exp Pharmacol; 2021; 264():395-423. PubMed ID: 32809100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes.
    Yamagishi S; Maeda S; Matsui T; Ueda S; Fukami K; Okuda S
    Biochim Biophys Acta; 2012 May; 1820(5):663-71. PubMed ID: 21440603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer.
    Forsythe ME; Love DC; Lazarus BD; Kim EJ; Prinz WA; Ashwell G; Krause MW; Hanover JA
    Proc Natl Acad Sci U S A; 2006 Aug; 103(32):11952-7. PubMed ID: 16882729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.